The Discounted Cash Flow (DCF) valuation of Yumanity Therapeutics Inc (YMTX) is (138.37) USD. With the latest stock price at 1.89 USD, the upside of Yumanity Therapeutics Inc based on DCF is -7421.3%.
Based on the latest price of 1.89 USD and our DCF valuation, Yumanity Therapeutics Inc (YMTX) is a sell. selling YMTX stocks now will result in a potential gain of 7421.3%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.9% - 7.7% | 6.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (422.51) - (85.55) | (138.37) |
| Upside | -22455.2% - -4626.3% | -7421.3% |